Suscribirse

Sex Differences in Symptom Phenotypes Among Older Patients with Acute Myocardial Infarction - 03/03/22

Doi : 10.1016/j.amjmed.2021.09.022 
John E. Brush, MD a, , Alexandra M. Hajduk, PhD, MPH b, Erich J. Greene, PhD c, Rachel P. Dreyer, PhD d, e, Harlan M. Krumholz, MD, SM c, d, e, Sarwat I. Chaudhry, MD f
a Sentara Healthcare and Eastern Virginia Medical School, Norfolk 
b Section of Geriatrics, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn 
c Department of Health Policy and Management and Department of Biostatistics, Yale School of Medicine, New Haven, Conn 
d Section of Cardiovascular Medicine, Department of Internal Medicine and Department of Emergency Medicine, Yale School of Medicine, New Haven, Conn 
e Yale School of Public Health; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Conn 
f Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn 

Requests for reprints should be addressed to John E. Brush, Jr., MD, Sentara Healthcare and Eastern Virginia Medical School, 835 Glenrock Road, Suite 220, Norfolk, VA, 23502.Sentara Healthcare and Eastern Virginia Medical School835 Glenrock Road, Suite 220NorfolkVA,23502

Abstract

Background

Clinicians make a medical diagnosis by recognizing diagnostic possibilities, often using memories of prior examples. These memories, called “exemplars,” reflect specific symptom combinations in individual patients, yet most clinical studies report how symptoms aggregate in populations. We studied how symptoms of acute myocardial infarction combine in individuals as symptom phenotypes and how symptom phenotypes are distributed in women and men.

Methods

In this analysis of the SILVER-AMI Study, we studied 3041 patients (1346 women and 1645 men) 75 years of age or older with acute myocardial infarction. Each patient had a standardized in-person interview during the acute myocardial infarction admission to document the presenting symptoms, which enabled a thorough examination of symptom combinations in individuals. Specific symptom combinations defined symptom phenotypes and distributions of symptom phenotypes were compared in women and men using Monte Carlo permutation testing and repeated subsampling.

Results

There were 1469 unique symptom phenotypes in the entire SILVER-AMI cohort of patients with acute myocardial infarction. There were 831 unique symptom phenotypes in women, as compared with 819 in men, which was highly significant, given the larger number of men than women in the study (P < .0001). Women had significantly more symptom phenotypes than men in almost all acute myocardial infarction subgroups.

Conclusions

Older patients with acute myocardial infarction have enormous variation in symptom phenotypes. Women reported more symptoms and had significantly more symptom phenotypes than men. Appreciation of the diversity of symptom phenotypes may help clinicians recognize the less common phenotypes that occur more often in women.

El texto completo de este artículo está disponible en PDF.

Keywords : Acute myocardial infarction, Diagnostic reasoning, Gender disparities


Esquema


 Funding: This research was supported by grant R01 HL115295 from the National Heart, Lung, and Blood Institute. This SILVER-AMI study was conducted at the Yale Claude D. Pepper Older Americans Independence Center (grant P30 AG021342).
 Conflicts of Interest: AMH, EJG, RPD report none. JEBJ receives royalties from Dementi Milestone Publishing for the book The Science of the Art of Medicine: A Guide to Medical Reasoning. HMK reports expenses and/or personal fees from UnitedHealth, IBM Watson Health, Element Science, Aetna, Facebook, the Siegfried and Jensen Law Firm, Arnold and Porter Law Firm, Martin/Baughman Law Firm, F-Prime, and the National Center for Cardiovascular Diseases in Beijing; being a cofounder of Refactor Health and HugoHealth; and grants and/or contracts from the Centers for Medicare & Medicaid Services, Medtronic, US Food and Drug Administration, Johnson & Johnson, Foundation for a Smoke-Free World, State of Connecticut Department of Public Health, and the Shenzhen Center for Health Information. SIC reports serving as a reviewer for the CVS Caremark State of Connecticut Clinical Program. The other authors report no disclosures.
 Authorship: All authors had access to the data and a role in writing this manuscript.


© 2021  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 135 - N° 3

P. 342-349 - mars 2022 Regresar al número
Artículo precedente Artículo precedente
  • Reducing ICU Utilization, Length of Stay, and Cost by Optimizing the Clinical Use of Continuous Monitoring System Technology in the Hospital
  • Patricia C. Dykes, Graham Lowenthal, Stuart Lipsitz, Suzanne M. Salvucci, Catherine Yoon, David W. Bates, Perry G. An
| Artículo siguiente Artículo siguiente
  • The Impact of an Inpatient Pancreatitis Service and Educational Intervention Program on the Outcome of Acute Pancreatitis
  • Cinthana Kandasamy, Ishani Shah, William Yakah, Awais Ahmed, Supisara Tintara, Cristina Sorrento, Steven D. Freedman, Darshan J. Kothari, Sunil G. Sheth

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.